Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fry

Showing results (701-710 of 737) with videos related to

Pageof 74
Sort By:
The Journal of Infectious Diseases|January 7, 1998
A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study GroupJ E Feinberg, S Hurwitz, D Cooper, et al.
Pediatric Blood & Cancer|January 26, 2020
Disease detection methodologies in relapsed B-cell acute lymphoblastic leukemia: Opportunities for improvementHaneen Shalabi, Constance M Yuan, Amita Kulshreshtha, et al.
Blood|October 6, 2022
Murine allogeneic CAR T cells integrated before or early after posttransplant cyclophosphamide exert antitumor effectsMichael T Patterson, Shanzay M Khan, Natalia S Nunes, et al.
Nature Communications|April 10, 2023
Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized miceXiaomeng Hu, Karl Manner, Rowena DeJesus, et al.
Blood|December 3, 2014
Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantationNirali N Shah, Kristin Baird, Cynthia P Delbrook, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
Chimeric Antigen Receptor T-Cell TherapyNdiya Ogba, Nicole M Arwood, Nancy L Bartlett, et al.
Journal for Immunotherapy of Cancer|June 9, 2023
CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicityJennifer Jess, Bonnie Yates, Alina Dulau-Florea, et al.
Nature Communications|July 28, 2016
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticityElad Jacoby, Sang M Nguyen, Thomas J Fountaine, et al.
Blood|June 5, 2015
Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoproteinHaiying Qin, Monica Cho, Waleed Haso, et al.
Journal for Immunotherapy of Cancer|November 28, 2020
Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemiaGeorge Mo, Hao-Wei Wang, Aimee C Talleur, et al.
Pageof 74

Showing results (701-710 of 737) with videos related to

Sort By:
Pageof 74
The Journal of Infectious Diseases|January 7, 1998
A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study GroupJ E Feinberg, S Hurwitz, D Cooper, et al.
Pediatric Blood & Cancer|January 26, 2020
Disease detection methodologies in relapsed B-cell acute lymphoblastic leukemia: Opportunities for improvementHaneen Shalabi, Constance M Yuan, Amita Kulshreshtha, et al.
Blood|October 6, 2022
Murine allogeneic CAR T cells integrated before or early after posttransplant cyclophosphamide exert antitumor effectsMichael T Patterson, Shanzay M Khan, Natalia S Nunes, et al.
Nature Communications|April 10, 2023
Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized miceXiaomeng Hu, Karl Manner, Rowena DeJesus, et al.
Blood|December 3, 2014
Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantationNirali N Shah, Kristin Baird, Cynthia P Delbrook, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
Chimeric Antigen Receptor T-Cell TherapyNdiya Ogba, Nicole M Arwood, Nancy L Bartlett, et al.
Journal for Immunotherapy of Cancer|June 9, 2023
CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicityJennifer Jess, Bonnie Yates, Alina Dulau-Florea, et al.
Nature Communications|July 28, 2016
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticityElad Jacoby, Sang M Nguyen, Thomas J Fountaine, et al.
Blood|June 5, 2015
Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoproteinHaiying Qin, Monica Cho, Waleed Haso, et al.
Journal for Immunotherapy of Cancer|November 28, 2020
Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemiaGeorge Mo, Hao-Wei Wang, Aimee C Talleur, et al.
Pageof 74